Pregabalin Exerts Oppositional Effects on Different Inhibitory Circuits in Human Motor Cortex: A Double‐blind, Placebo‐controlled Transcranial Magnetic Stimulation Study

Purpose: To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).  Methods: PGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double‐blind, placebo‐controlled crossover design. Several mea...

Full description

Saved in:
Bibliographic Details
Published inEpilepsia (Copenhagen) Vol. 47; no. 5; pp. 813 - 819
Main Authors Lang, Nicolas, Sueske, Elke, Hasan, Alkomiet, Paulus, Walter, Tergau, Frithjof
Format Journal Article
LanguageEnglish
Published Malden, USA Blackwell Publishing Inc 01.05.2006
Blackwell
Subjects
Online AccessGet full text
ISSN0013-9580
1528-1157
1528-1167
1528-1167
DOI10.1111/j.1528-1167.2006.00544.x

Cover

Abstract Purpose: To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).  Methods: PGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double‐blind, placebo‐controlled crossover design. Several measures of motor cortex excitability were tested with single‐ and paired‐pulse TMS.  Results: Mean short‐interval intracortical inhibition (SICI) was reduced after PGB (74 ± 7% of unconditioned response) compared with placebo (60 ± 6% of unconditioned response). In contrast, mean long‐interval intracortical inhibition (LICI) was increased by PGB (26 ± 4% of unconditioned response) compared with placebo (45 ± 8% of unconditioned response), and mean cortical silent period (CSP) showed an increase from 139 ± 8 ms or 145 ± 8 ms after placebo to 162 ± 7 ms or 161 ± 10 ms after PGB. Motor thresholds, intracortical facilitation, and corticospinal excitability were unaffected.  Conclusions: The observed excitability changes with oppositional effects on SICI and LICI or CSP suggest γ‐aminobutyric acid (GABA)B‐receptor activation. They are markedly distinct from those induced by gabapentin, although both PGB and gabapentin are thought to mediate their function by binding to the α(2)‐δ subunit of voltage‐gated calcium channels. Conversely, the TMS profile of PGB shows striking similarities with the pattern evoked by the GABA‐reuptake inhibitor tiagabine.
AbstractList To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).PURPOSETo explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).PGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double-blind, placebo-controlled crossover design. Several measures of motor cortex excitability were tested with single- and paired-pulse TMS.METHODSPGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double-blind, placebo-controlled crossover design. Several measures of motor cortex excitability were tested with single- and paired-pulse TMS.Mean short-interval intracortical inhibition (SICI) was reduced after PGB (74 +/- 7% of unconditioned response) compared with placebo (60 +/- 6% of unconditioned response). In contrast, mean long-interval intracortical inhibition (LICI) was increased by PGB (26 +/- 4% of unconditioned response) compared with placebo (45 +/- 8% of unconditioned response), and mean cortical silent period (CSP) showed an increase from 139 +/- 8 ms or 145 +/- 8 ms after placebo to 162 +/- 7 ms or 161 +/- 10 ms after PGB. Motor thresholds, intracortical facilitation, and corticospinal excitability were unaffected.RESULTSMean short-interval intracortical inhibition (SICI) was reduced after PGB (74 +/- 7% of unconditioned response) compared with placebo (60 +/- 6% of unconditioned response). In contrast, mean long-interval intracortical inhibition (LICI) was increased by PGB (26 +/- 4% of unconditioned response) compared with placebo (45 +/- 8% of unconditioned response), and mean cortical silent period (CSP) showed an increase from 139 +/- 8 ms or 145 +/- 8 ms after placebo to 162 +/- 7 ms or 161 +/- 10 ms after PGB. Motor thresholds, intracortical facilitation, and corticospinal excitability were unaffected.The observed excitability changes with oppositional effects on SICI and LICI or CSP suggest gamma-aminobutyric acid (GABA)B-receptor activation. They are markedly distinct from those induced by gabapentin, although both PGB and gabapentin are thought to mediate their function by binding to the alpha2-delta subunit of voltage-gated calcium channels. Conversely, the TMS profile of PGB shows striking similarities with the pattern evoked by the GABA-reuptake inhibitor tiagabine.CONCLUSIONSThe observed excitability changes with oppositional effects on SICI and LICI or CSP suggest gamma-aminobutyric acid (GABA)B-receptor activation. They are markedly distinct from those induced by gabapentin, although both PGB and gabapentin are thought to mediate their function by binding to the alpha2-delta subunit of voltage-gated calcium channels. Conversely, the TMS profile of PGB shows striking similarities with the pattern evoked by the GABA-reuptake inhibitor tiagabine.
Purpose: To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).  Methods: PGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double‐blind, placebo‐controlled crossover design. Several measures of motor cortex excitability were tested with single‐ and paired‐pulse TMS.  Results: Mean short‐interval intracortical inhibition (SICI) was reduced after PGB (74 ± 7% of unconditioned response) compared with placebo (60 ± 6% of unconditioned response). In contrast, mean long‐interval intracortical inhibition (LICI) was increased by PGB (26 ± 4% of unconditioned response) compared with placebo (45 ± 8% of unconditioned response), and mean cortical silent period (CSP) showed an increase from 139 ± 8 ms or 145 ± 8 ms after placebo to 162 ± 7 ms or 161 ± 10 ms after PGB. Motor thresholds, intracortical facilitation, and corticospinal excitability were unaffected.  Conclusions: The observed excitability changes with oppositional effects on SICI and LICI or CSP suggest γ‐aminobutyric acid (GABA)B‐receptor activation. They are markedly distinct from those induced by gabapentin, although both PGB and gabapentin are thought to mediate their function by binding to the α(2)‐δ subunit of voltage‐gated calcium channels. Conversely, the TMS profile of PGB shows striking similarities with the pattern evoked by the GABA‐reuptake inhibitor tiagabine.
Purpose: To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).   Methods: PGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double‐blind, placebo‐controlled crossover design. Several measures of motor cortex excitability were tested with single‐ and paired‐pulse TMS.   Results: Mean short‐interval intracortical inhibition (SICI) was reduced after PGB (74 ± 7% of unconditioned response) compared with placebo (60 ± 6% of unconditioned response). In contrast, mean long‐interval intracortical inhibition (LICI) was increased by PGB (26 ± 4% of unconditioned response) compared with placebo (45 ± 8% of unconditioned response), and mean cortical silent period (CSP) showed an increase from 139 ± 8 ms or 145 ± 8 ms after placebo to 162 ± 7 ms or 161 ± 10 ms after PGB. Motor thresholds, intracortical facilitation, and corticospinal excitability were unaffected.   Conclusions: The observed excitability changes with oppositional effects on SICI and LICI or CSP suggest γ‐aminobutyric acid (GABA) B ‐receptor activation. They are markedly distinct from those induced by gabapentin, although both PGB and gabapentin are thought to mediate their function by binding to the α(2)‐δ subunit of voltage‐gated calcium channels. Conversely, the TMS profile of PGB shows striking similarities with the pattern evoked by the GABA‐reuptake inhibitor tiagabine.
To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS). PGB, 600 mg/day, was orally administered in 19 healthy subjects twice daily in a randomized, double-blind, placebo-controlled crossover design. Several measures of motor cortex excitability were tested with single- and paired-pulse TMS. Mean short-interval intracortical inhibition (SICI) was reduced after PGB (74 +/- 7% of unconditioned response) compared with placebo (60 +/- 6% of unconditioned response). In contrast, mean long-interval intracortical inhibition (LICI) was increased by PGB (26 +/- 4% of unconditioned response) compared with placebo (45 +/- 8% of unconditioned response), and mean cortical silent period (CSP) showed an increase from 139 +/- 8 ms or 145 +/- 8 ms after placebo to 162 +/- 7 ms or 161 +/- 10 ms after PGB. Motor thresholds, intracortical facilitation, and corticospinal excitability were unaffected. The observed excitability changes with oppositional effects on SICI and LICI or CSP suggest gamma-aminobutyric acid (GABA)B-receptor activation. They are markedly distinct from those induced by gabapentin, although both PGB and gabapentin are thought to mediate their function by binding to the alpha2-delta subunit of voltage-gated calcium channels. Conversely, the TMS profile of PGB shows striking similarities with the pattern evoked by the GABA-reuptake inhibitor tiagabine.
Author Paulus, Walter
Tergau, Frithjof
Lang, Nicolas
Hasan, Alkomiet
Sueske, Elke
Author_xml – sequence: 1
  givenname: Nicolas
  surname: Lang
  fullname: Lang, Nicolas
– sequence: 2
  givenname: Elke
  surname: Sueske
  fullname: Sueske, Elke
– sequence: 3
  givenname: Alkomiet
  surname: Hasan
  fullname: Hasan, Alkomiet
– sequence: 4
  givenname: Walter
  surname: Paulus
  fullname: Paulus, Walter
– sequence: 5
  givenname: Frithjof
  surname: Tergau
  fullname: Tergau, Frithjof
BackLink http://pascal-francis.inist.fr/vibad/index.php?action=getRecordDetail&idt=17835066$$DView record in Pascal Francis
https://www.ncbi.nlm.nih.gov/pubmed/16686645$$D View this record in MEDLINE/PubMed
BookMark eNqVUUFu1DAUtVARnRaugLyBFQl2EtsJQkjVdKAjtepIlLXlOE7xyGOntqPO7DgCF-FSnASnM6ISq-KF_fX93n9f752AI-usAgBilON03q9zTIo6w5iyvECI5giRqsq3z8Ds78cRmCGEy6whNToGJyGsEUKMsvIFOMaU1pRWZAZ-rby6Fa0w2sLFVvkY4PUwuKCjdlYYuOh7JVPTWXiuU-2VjXBpv-tWR-d3cK69HHUCJP7FuBEWXrn0AefOR7X9AM_guRtbo37_-Nkmje4dXBkhVetSQzobvTNGdfDGCxtkunTSvBK3VkUt4deoN6MR0yqpHrvdS_C8FyaoV4f3FHz7vLiZX2SX11-W87PLTFYMV1nBJC1KSohEVVGQqkGklAVpUd0VGEtW9C1WDatKSWuJREN6ihjBSvYMdUWLy1PQ7OeOdhC7e2EMH7zeCL_jGPEpAr7mk9N8cppPEfCHCPg2cd_uuYN3d6MKkW90kMoYYZUbA6esIayqJpHXB-DYblT3qHAIJwHeHAAiSGH6ZI_U4RHH6pIgShOu3uOkdyF41f_Psp_-oUodHwyPXmjzlAEf9wPutVG7JwvzxWqZivIPbsDaUA
CODEN EPILAK
CitedBy_id crossref_primary_10_1016_j_neubiorev_2017_10_006
crossref_primary_10_1097_WNP_0000000000000784
crossref_primary_10_3389_fpsyt_2021_676224
crossref_primary_10_4085_1062_6050_46_3_234
crossref_primary_10_1016_j_eplepsyres_2013_09_006
crossref_primary_10_1016_j_jsps_2020_11_001
crossref_primary_10_1111_j_1369_1600_2007_00093_x
crossref_primary_10_1016_j_smrv_2024_102027
crossref_primary_10_1016_j_encep_2020_02_008
crossref_primary_10_1016_j_brs_2008_06_002
crossref_primary_10_1080_00952990_2025_2467458
crossref_primary_10_1093_cercor_bhr003
crossref_primary_10_1016_j_eplepsyres_2016_06_004
crossref_primary_10_1097_j_pain_0000000000000324
crossref_primary_10_1517_17425255_2013_749239
crossref_primary_10_1016_j_clinph_2011_11_034
crossref_primary_10_1016_j_parkreldis_2024_107151
crossref_primary_10_1016_j_clinph_2014_08_028
crossref_primary_10_1016_j_jsps_2023_101935
crossref_primary_10_3390_brainsci11060705
crossref_primary_10_1007_s00421_014_2884_z
crossref_primary_10_1016_j_neurol_2010_10_013
crossref_primary_10_1038_s41598_019_51556_4
crossref_primary_10_1186_1471_2377_13_43
crossref_primary_10_1007_s40263_015_0303_6
crossref_primary_10_1016_j_brs_2016_04_019
crossref_primary_10_3389_fnhum_2018_00406
crossref_primary_10_1016_j_seizure_2013_05_010
crossref_primary_10_1016_j_medidd_2021_100083
crossref_primary_10_1016_j_clinph_2006_05_030
crossref_primary_10_1586_14737175_8_7_1013
crossref_primary_10_1016_j_neuroscience_2015_05_057
crossref_primary_10_1016_j_brs_2016_11_009
crossref_primary_10_1016_j_sleep_2015_03_018
Cites_doi 10.1111/j.1600-0404.1996.tb00047.x
10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.0.CO;2-M
10.1016/0028-3932(71)90067-4
10.1176/appi.ajp.160.3.533
10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B
10.1016/S0028-3908(01)00140-X
10.1212/01.WNL.0000068024.20285.65
10.1046/j.1528-1157.2001.01600.x
10.1016/S0028-3908(01)00181-2
10.1016/S1059-1311(02)00295-9
10.1124/mol.59.1.144
10.1111/j.0013-9580.2004.31203.x
10.1016/j.eplepsyres.2003.08.006
10.1016/S0304-3959(03)00173-8
10.1016/S0304-3959(01)00316-5
10.1016/j.clinph.2004.03.006
10.1016/0168-5597(92)90048-G
10.1016/S0304-3940(00)00769-2
10.1111/j.1469-7793.2001.0307l.x
10.1007/s100720100002
10.1212/01.WNL.0000038744.30298.D4
10.1016/S0924-980X(98)00038-1
10.1212/01.WNL.0000145767.36287.A1
10.1016/S0022-3565(24)29346-0
10.1016/S0028-3908(01)00172-1
10.1038/sj.bjp.0704439
10.1093/brain/awh398
10.1124/mol.61.6.1377
10.1111/j.1469-7793.1999.0591t.x
10.1002/ana.10473
10.1053/seiz.2001.0594
10.1002/ana.410400306
10.1152/jn.1992.67.6.1698
10.1113/jphysiol.1993.sp019912
10.1016/S0074-7742(08)60304-9
10.1212/WNL.49.3.881
10.1002/ana.410370204
10.1212/01.WNL.0000055433.55136.55
10.1016/j.clinph.2004.12.004
10.1212/01.WNL.0000150932.48688.BE
10.1152/jn.1992.67.1.227
10.1007/BF00228633
10.1111/j.1469-7793.1998.181bi.x
ContentType Journal Article
Copyright 2006 INIST-CNRS
Copyright_xml – notice: 2006 INIST-CNRS
DBID AAYXX
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
DOI 10.1111/j.1528-1167.2006.00544.x
DatabaseName CrossRef
Pascal-Francis
Medline
MEDLINE
MEDLINE (Ovid)
MEDLINE
MEDLINE
PubMed
MEDLINE - Academic
Unpaywall for CDI: Periodical Content
Unpaywall
DatabaseTitle CrossRef
MEDLINE
Medline Complete
MEDLINE with Full Text
PubMed
MEDLINE (Ovid)
MEDLINE - Academic
DatabaseTitleList MEDLINE - Academic

CrossRef
MEDLINE
Database_xml – sequence: 1
  dbid: NPM
  name: PubMed
  url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed
  sourceTypes: Index Database
– sequence: 2
  dbid: EIF
  name: MEDLINE
  url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search
  sourceTypes: Index Database
– sequence: 3
  dbid: UNPAY
  name: Unpaywall
  url: https://proxy.k.utb.cz/login?url=https://unpaywall.org/
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
EISSN 1528-1167
EndPage 819
ExternalDocumentID 10.1111/j.1528-1167.2006.00544.x
16686645
17835066
10_1111_j_1528_1167_2006_00544_x
EPI544
Genre article
Randomized Controlled Trial
Journal Article
Comparative Study
GroupedDBID ---
.3N
.55
.GA
.GJ
.Y3
05W
0R~
10A
1OB
1OC
24P
29G
2WC
31~
33P
36B
3SF
4.4
50Y
50Z
51W
51X
52M
52N
52O
52P
52R
52S
52T
52U
52V
52W
52X
53G
5GY
5HH
5LA
5RE
5VS
66C
702
7PT
8-0
8-1
8-3
8-4
8-5
8UM
930
A01
A03
AAESR
AAEVG
AAGKA
AAHHS
AAHQN
AAIPD
AAMNL
AANHP
AANLZ
AAONW
AASGY
AAXRX
AAYCA
AAZKR
ABCQN
ABCUV
ABEML
ABIVO
ABJNI
ABLJU
ABPVW
ABQWH
ABXGK
ACAHQ
ACBWZ
ACCFJ
ACCZN
ACGFO
ACGFS
ACGOF
ACMXC
ACPOU
ACPRK
ACRPL
ACSCC
ACXBN
ACXQS
ACYXJ
ADBBV
ADBTR
ADEOM
ADIZJ
ADKYN
ADMGS
ADNMO
ADOZA
ADXAS
ADZMN
ADZOD
AEEZP
AEIGN
AEIMD
AENEX
AEQDE
AEUQT
AEUYR
AFBPY
AFEBI
AFFPM
AFGKR
AFPWT
AFWVQ
AFZJQ
AHBTC
AHEFC
AI.
AIACR
AIAGR
AITYG
AIURR
AIWBW
AJBDE
ALAGY
ALMA_UNASSIGNED_HOLDINGS
ALUQN
ALVPJ
AMBMR
AMYDB
ASPBG
ATUGU
AVWKF
AZBYB
AZFZN
AZVAB
BAFTC
BAWUL
BDRZF
BFHJK
BHBCM
BMXJE
BROTX
BRXPI
BY8
C45
CAG
COF
CS3
D-6
D-7
D-E
D-F
DCZOG
DIK
DPXWK
DR2
DRFUL
DRMAN
DRSTM
DU5
E3Z
EBS
EJD
EMOBN
ESX
EX3
F00
F01
F04
F5P
FEDTE
FIJ
FUBAC
FYBCS
G-S
G.N
GODZA
H.X
HF~
HGLYW
HVGLF
HZI
HZ~
IHE
IPNFZ
IX1
J0M
K48
KBYEO
LATKE
LC2
LC3
LEEKS
LH4
LITHE
LOXES
LP6
LP7
LUTES
LW6
LYRES
MEWTI
MK4
MRFUL
MRMAN
MRSTM
MSFUL
MSMAN
MSSTM
MXFUL
MXMAN
MXSTM
N04
N05
N9A
NF~
O66
O9-
OHT
OIG
OK1
OVD
P2P
P2W
P2X
P2Z
P4B
P4D
PALCI
Q.N
Q11
QB0
R.K
RIWAO
RJQFR
ROL
RX1
SAMSI
SUPJJ
TEORI
TR2
UB1
V8K
V9Y
VH1
W8V
W99
WBKPD
WHWMO
WIH
WIJ
WIK
WIN
WOHZO
WOW
WQJ
WRC
WUP
WVDHM
WXI
WXSBR
X7M
XG1
YFH
YOC
YUY
ZGI
ZXP
ZZTAW
~IA
~WT
AAFWJ
AAMMB
AAYXX
AEFGJ
AEYWJ
AGHNM
AGQPQ
AGXDD
AGYGG
AIDQK
AIDYY
AIQQE
CITATION
IQODW
CGR
CUY
CVF
ECM
EIF
NPM
7X8
ADTOC
UNPAY
ID FETCH-LOGICAL-c4714-27c623655c0422549053c25b08d211c72fb1e9743c68c0a95f60751ecf70d2b13
IEDL.DBID UNPAY
ISSN 0013-9580
1528-1157
1528-1167
IngestDate Wed Oct 01 16:11:07 EDT 2025
Thu Oct 02 06:16:43 EDT 2025
Wed Feb 19 01:54:35 EST 2025
Mon Jul 21 09:11:52 EDT 2025
Thu Apr 24 23:01:11 EDT 2025
Wed Oct 01 04:32:27 EDT 2025
Wed Jan 22 16:27:08 EST 2025
IsDoiOpenAccess true
IsOpenAccess true
IsPeerReviewed true
IsScholarly true
Issue 5
Keywords Human
Nervous system diseases
Transcranial magnetic stimulation
Motor pathway
Calcium
Epilepsy
Central nervous system
Anticonvulsant
Pregabalin
Inorganic element
Cerebral disorder
Analgesic
Motor cortex
Central nervous system disease
Voltage
Neurotransmitter
GABA
Pregabalin-Transcranial magnetic stimulation-Intracortical inhibition-Silent period-GABA- Voltage-dependent calcium channel
Language English
License http://onlinelibrary.wiley.com/termsAndConditions#vor
CC BY 4.0
LinkModel DirectLink
MergedId FETCHMERGED-LOGICAL-c4714-27c623655c0422549053c25b08d211c72fb1e9743c68c0a95f60751ecf70d2b13
Notes ObjectType-Article-2
SourceType-Scholarly Journals-1
ObjectType-Feature-1
content type line 23
ObjectType-Undefined-3
OpenAccessLink https://proxy.k.utb.cz/login?url=https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1528-1167.2006.00544.x
PMID 16686645
PQID 67957441
PQPubID 23479
PageCount 7
ParticipantIDs unpaywall_primary_10_1111_j_1528_1167_2006_00544_x
proquest_miscellaneous_67957441
pubmed_primary_16686645
pascalfrancis_primary_17835066
crossref_primary_10_1111_j_1528_1167_2006_00544_x
crossref_citationtrail_10_1111_j_1528_1167_2006_00544_x
wiley_primary_10_1111_j_1528_1167_2006_00544_x_EPI544
ProviderPackageCode CITATION
AAYXX
PublicationCentury 2000
PublicationDate May 2006
PublicationDateYYYYMMDD 2006-05-01
PublicationDate_xml – month: 05
  year: 2006
  text: May 2006
PublicationDecade 2000
PublicationPlace Malden, USA
PublicationPlace_xml – name: Malden, USA
– name: Malden, MA
– name: United States
PublicationTitle Epilepsia (Copenhagen)
PublicationTitleAlternate Epilepsia
PublicationYear 2006
Publisher Blackwell Publishing Inc
Blackwell
Publisher_xml – name: Blackwell Publishing Inc
– name: Blackwell
References 2004; 63
2001; 93
2002; 59
1996; 109
1995; 37
2002; 135
2004; 45
2005; 116
2002; 11
1996; 94
2005; 64
2000; 295
1997; 49
1998; 511
2001; 22
1998; 21
2003; 53
2001; 41
2001; 42
2003; 12
2003; 56
2001; 298
1971; 9
2001; 530
2004; 115
2003; 105
2002; 42
2002; 61
1999; 19
2005; 128
2003; 160
1993; 471
1994; 36
1997; 38
1996; 40
1998; 109
2001; 59
1999; 52
2003; 60
1992; 67
1999; 517
2000; 280
1992; 85
e_1_2_6_31_2
e_1_2_6_30_2
e_1_2_6_18_2
e_1_2_6_19_2
e_1_2_6_13_2
e_1_2_6_34_2
Welty D (e_1_2_6_12_2) 1997; 38
e_1_2_6_33_2
e_1_2_6_11_2
e_1_2_6_32_2
e_1_2_6_16_2
e_1_2_6_39_2
e_1_2_6_17_2
e_1_2_6_38_2
e_1_2_6_14_2
e_1_2_6_37_2
e_1_2_6_15_2
e_1_2_6_36_2
Bertrand S (e_1_2_6_35_2) 2001; 298
e_1_2_6_42_2
Dooley DJ (e_1_2_6_10_2) 2000; 295
e_1_2_6_41_2
e_1_2_6_40_2
e_1_2_6_8_2
e_1_2_6_7_2
e_1_2_6_9_2
e_1_2_6_29_2
e_1_2_6_4_2
e_1_2_6_3_2
e_1_2_6_6_2
e_1_2_6_5_2
e_1_2_6_24_2
e_1_2_6_47_2
e_1_2_6_23_2
e_1_2_6_2_2
e_1_2_6_22_2
e_1_2_6_21_2
Rothwell JC (e_1_2_6_20_2) 1999; 52
e_1_2_6_28_2
e_1_2_6_43_2
e_1_2_6_27_2
e_1_2_6_44_2
e_1_2_6_26_2
e_1_2_6_45_2
e_1_2_6_25_2
e_1_2_6_46_2
References_xml – volume: 295
  start-page: 1086
  year: 2000
  end-page: 1093
  article-title: Stimulus‐dependent modulation of [(3)H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin
  publication-title: J Pharmacol Exp Ther
– volume: 38
  start-page: 35
  issue: suppl 8
  year: 1997
  end-page: 36
  article-title: Pharmacokinetics (PK) and pharmacodynamics (PD) of CI‐1008 (pregabalin) and gabapentin in rats with maximal electroshock
  publication-title: Epilepsia
– volume: 109
  start-page: 127
  year: 1996
  end-page: 135
  article-title: The effect of lorazepam on the motor cortical excitability in man
  publication-title: Exp Brain Res
– volume: 40
  start-page: 367
  year: 1996
  end-page: 378
  article-title: Effects of antiepileptic drugs on motor cortex excitability in humans: a transcranial magnetic stimulation study
  publication-title: Ann Neurol
– volume: 85
  start-page: 355
  year: 1992
  end-page: 364
  article-title: Human motor evoked responses to paired transcranial magnetic stimuli
  publication-title: Electroencephalogr Clin Neurophysiol
– volume: 42
  start-page: 353
  year: 2002
  end-page: 366
  article-title: Gabapentin‐mediated inhibition of voltage‐activated Ca2 channel currents in cultured sensory neurones is dependent on culture conditions and channel subunit expression
  publication-title: Neuropharmacology
– volume: 19
  start-page: 149
  year: 1999
  end-page: 177
  article-title: 3‐Substituted GABA analogs with central nervous system activity: a review
  publication-title: Med Res Rev
– volume: 22
  start-page: 229
  year: 2001
  end-page: 232
  article-title: Modification of cortical excitability induced by gabapentin: a study by transcranial magnetic stimulation
  publication-title: Neurol Sci
– volume: 109
  start-page: 397
  year: 1998
  end-page: 401
  article-title: Comparison of descending volleys evoked by transcranial magnetic and electric stimulation in conscious humans
  publication-title: Electroencephalogr Clin Neurophysiol
– volume: 45
  start-page: 20
  year: 2004
  end-page: 27
  article-title: Pregabalin add‐on treatment: a randomized, double‐blind, placebo‐controlled, dose‐response study in adults with partial seizures
  publication-title: Epilepsia
– volume: 41
  start-page: 965
  year: 2001
  end-page: 975
  article-title: Gabapentin is not a GABA receptor agonist
  publication-title: Neuropharmacology
– volume: 116
  start-page: 1105
  year: 2005
  end-page: 1112
  article-title: Cortical excitability during prolonged antiepileptic drug treatment and drug withdrawal
  publication-title: Clin Neurophysiol
– volume: 94
  start-page: 367
  year: 1996
  end-page: 377
  article-title: Seizure‐inducing effects of antiepileptic drugs: a review
  publication-title: Acta Neurol Scand
– volume: 93
  start-page: 191
  year: 2001
  end-page: 196
  article-title: Gabapentin inhibits the substance P‐facilitated K(+)‐evoked release of ((3)H)glutamate from rat caudal trigeminal nucleus slices
  publication-title: Pain
– volume: 59
  start-page: 1851
  year: 2002
  end-page: 1859
  article-title: Transcranial magnetic stimulation techniques in clinical investigation
  publication-title: Neurology
– volume: 280
  start-page: 107
  year: 2000
  end-page: 110
  article-title: Inhibition of K( )‐evoked glutamate release from rat neocortical and hippocampal slices by gabapentin
  publication-title: Neurosci Lett
– volume: 67
  start-page: 1698
  year: 1992
  end-page: 1701
  article-title: Effects of the GABA uptake inhibitor tiagabine on inhibitory synaptic potentials in rat hippocampal slice cultures
  publication-title: J Neurophysiol
– volume: 11
  start-page: 243
  year: 2002
  end-page: 249
  article-title: Tiagabine‐related non‐convulsive status epilepticus in partial epilepsy: three case reports and a review of the literature
  publication-title: Seizure
– volume: 59
  start-page: 144
  year: 2001
  end-page: 152
  article-title: Gamma‐aminobutyric acid type B receptors with specific heterodimer composition and postsynaptic actions in hippocampal neurons are targets of anticonvulsant gabapentin action
  publication-title: Mol Pharmacol
– volume: 517
  start-page: 591
  year: 1999
  end-page: 597
  article-title: Differential effects on motorcortical inhibition induced by blockade of GABA uptake in humans
  publication-title: J Physiol
– volume: 9
  start-page: 97
  year: 1971
  end-page: 113
  article-title: The assessment and analysis of handedness: the Edinburgh inventory
  publication-title: Neuropsychologia
– volume: 42
  start-page: 372
  year: 2001
  end-page: 379
  article-title: Status epilepticus and tiagabine therapy: review of safety data and epidemiologic comparisons
  publication-title: Epilepsia
– volume: 63
  start-page: 2104
  year: 2004
  end-page: 2110
  article-title: Pregabalin relieves symptoms of painful diabetic neuropathy: a randomized controlled trial
  publication-title: Neurology
– volume: 471
  start-page: 501
  year: 1993
  end-page: 519
  article-title: Corticocortical inhibition in human motor cortex
  publication-title: J Physiol (Lond)
– volume: 64
  start-page: 475
  year: 2005
  end-page: 480
  article-title: Safety and efficacy of two pregabalin regimens for add‐on treatment of partial epilepsy
  publication-title: Neurology
– volume: 56
  start-page: 67
  year: 2003
  end-page: 77
  article-title: Relationship between lamotrigine oral dose, serum level and its inhibitory effect on CNS: insights from transcranial magnetic stimulation
  publication-title: Epilepsy Res
– volume: 36
  start-page: 97
  year: 1994
  end-page: 223
  article-title: The pharmacology and function of central GABA receptors
  publication-title: Int Rev Neurobiol
– volume: 61
  start-page: 1377
  year: 2002
  end-page: 1384
  article-title: The anticonvulsant gabapentin (Neurontin) does not act through gamma‐aminobutyric acid‐B receptors
  publication-title: Mol Pharmacol
– volume: 511
  start-page: 181
  year: 1998
  end-page: 190
  article-title: Demonstration of facilitatory I wave interaction in the human motor cortex by paired transcranial magnetic stimulation
  publication-title: J Physiol
– volume: 530
  start-page: 307
  year: 2001
  end-page: 317
  article-title: Interactions between two different inhibitory systems in the human motor cortex
  publication-title: J Physiol
– volume: 21
  start-page: 1209
  year: 1998
  end-page: 1212
  article-title: Continuous intrathecal baclofen infusions induced a marked increase of the transcranially evoked silent period in a patient with generalized dystonia
  publication-title: Muscle Nerve
– volume: 60
  start-page: 1274
  year: 2003
  end-page: 1283
  article-title: Pregabalin for the treatment of postherpetic neuralgia: a randomized, placebo‐controlled trial
  publication-title: Neurology
– volume: 128
  start-page: 811
  year: 2005
  end-page: 818.
  article-title: Motor cortex excitability in focal epilepsies not including the primary motor area: a TMS study
  publication-title: Brain
– volume: 67
  start-page: 227
  year: 1992
  end-page: 235
  article-title: Differential activation of GABA and GABA receptors by spontaneously released transmitter
  publication-title: J Neurophysiol
– volume: 12
  start-page: 300
  year: 2003
  end-page: 306
  article-title: Acute effects of gabapentin and pregabalin on rat forebrain cellular GABA, glutamate, and glutamine concentrations
  publication-title: Seizure
– volume: 115
  start-page: 1717
  year: 2004
  end-page: 1729
  article-title: TMS and drugs
  publication-title: Clin Neurophysiol
– volume: 135
  start-page: 257
  year: 2002
  end-page: 265
  article-title: Gabapentin inhibits high‐threshold calcium channel currents in cultured rat dorsal root ganglion neurones
  publication-title: Br J Pharmacol
– volume: 37
  start-page: 146
  year: 1995
  end-page: 157
  article-title: Basic mechanisms of generalized absence seizures
  publication-title: Ann Neurol
– volume: 42
  start-page: 229
  year: 2002
  end-page: 236
  article-title: Inhibition of neuronal Ca(2 ) influx by gabapentin and pregabalin in the human neocortex
  publication-title: Neuropharmacology
– volume: 53
  start-page: 469
  year: 2003
  end-page: 479
  article-title: A novel mechanism underlying drug resistance in chronic epilepsy
  publication-title: Ann Neurol
– volume: 49
  start-page: 881
  year: 1997
  end-page: 883
  article-title: Effects of phenytoin on cortical excitability in humans
  publication-title: Neurology
– volume: 105
  start-page: 133
  year: 2003
  end-page: 141
  article-title: Pregabalin and gabapentin reduce release of substance P and CGRP from rat spinal tissues only after inflammation or activation of protein kinase C
  publication-title: Pain
– volume: 52
  start-page: 97
  year: 1999
  end-page: 103
  article-title: Magnetic stimulation: motor evoked potentials: the International Federation of Clinical Neurophysiology
  publication-title: Electroencephalogr Clin Neurophysiol Suppl
– volume: 160
  start-page: 533
  year: 2003
  end-page: 540
  article-title: Pregabalin in generalized anxiety disorder: a placebo‐controlled trial
  publication-title: Am J Psychiatry
– volume: 298
  start-page: 15
  year: 2001
  end-page: 24
  article-title: The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma‐aminobutyric acid type B receptors negatively coupled to voltage‐dependent calcium channels
  publication-title: J Pharmacol Exp Ther
– volume: 60
  start-page: 1631
  year: 2003
  end-page: 1637
  article-title: Dose‐response trial of pregabalin adjunctive therapy in patients with partial seizures
  publication-title: Neurology
– ident: e_1_2_6_47_2
  doi: 10.1111/j.1600-0404.1996.tb00047.x
– ident: e_1_2_6_30_2
  doi: 10.1002/(SICI)1097-4598(199809)21:9<1209::AID-MUS15>3.0.CO;2-M
– ident: e_1_2_6_18_2
  doi: 10.1016/0028-3932(71)90067-4
– ident: e_1_2_6_7_2
  doi: 10.1176/appi.ajp.160.3.533
– volume: 38
  start-page: 35
  issue: 8
  year: 1997
  ident: e_1_2_6_12_2
  article-title: Pharmacokinetics (PK) and pharmacodynamics (PD) of CI‐1008 (pregabalin) and gabapentin in rats with maximal electroshock
  publication-title: Epilepsia
– ident: e_1_2_6_43_2
  doi: 10.1002/(SICI)1098-1128(199903)19:2<149::AID-MED3>3.0.CO;2-B
– ident: e_1_2_6_37_2
  doi: 10.1016/S0028-3908(01)00140-X
– ident: e_1_2_6_3_2
  doi: 10.1212/01.WNL.0000068024.20285.65
– volume: 52
  start-page: 97
  year: 1999
  ident: e_1_2_6_20_2
  article-title: Magnetic stimulation: motor evoked potentials: the International Federation of Clinical Neurophysiology
  publication-title: Electroencephalogr Clin Neurophysiol Suppl
– ident: e_1_2_6_45_2
  doi: 10.1046/j.1528-1157.2001.01600.x
– volume: 295
  start-page: 1086
  year: 2000
  ident: e_1_2_6_10_2
  article-title: Stimulus‐dependent modulation of [(3)H]norepinephrine release from rat neocortical slices by gabapentin and pregabalin
  publication-title: J Pharmacol Exp Ther
– ident: e_1_2_6_38_2
  doi: 10.1016/S0028-3908(01)00181-2
– ident: e_1_2_6_13_2
  doi: 10.1016/S1059-1311(02)00295-9
– ident: e_1_2_6_34_2
  doi: 10.1124/mol.59.1.144
– ident: e_1_2_6_2_2
  doi: 10.1111/j.0013-9580.2004.31203.x
– ident: e_1_2_6_24_2
  doi: 10.1016/j.eplepsyres.2003.08.006
– ident: e_1_2_6_11_2
  doi: 10.1016/S0304-3959(03)00173-8
– ident: e_1_2_6_40_2
  doi: 10.1016/S0304-3959(01)00316-5
– ident: e_1_2_6_16_2
  doi: 10.1016/j.clinph.2004.03.006
– ident: e_1_2_6_22_2
  doi: 10.1016/0168-5597(92)90048-G
– ident: e_1_2_6_9_2
  doi: 10.1016/S0304-3940(00)00769-2
– ident: e_1_2_6_33_2
  doi: 10.1111/j.1469-7793.2001.0307l.x
– ident: e_1_2_6_17_2
  doi: 10.1007/s100720100002
– ident: e_1_2_6_15_2
  doi: 10.1212/01.WNL.0000038744.30298.D4
– ident: e_1_2_6_19_2
  doi: 10.1016/S0924-980X(98)00038-1
– ident: e_1_2_6_5_2
  doi: 10.1212/01.WNL.0000145767.36287.A1
– volume: 298
  start-page: 15
  year: 2001
  ident: e_1_2_6_35_2
  article-title: The anticonvulsant, antihyperalgesic agent gabapentin is an agonist at brain gamma‐aminobutyric acid type B receptors negatively coupled to voltage‐dependent calcium channels
  publication-title: J Pharmacol Exp Ther
  doi: 10.1016/S0022-3565(24)29346-0
– ident: e_1_2_6_8_2
  doi: 10.1016/S0028-3908(01)00172-1
– ident: e_1_2_6_39_2
  doi: 10.1038/sj.bjp.0704439
– ident: e_1_2_6_25_2
  doi: 10.1093/brain/awh398
– ident: e_1_2_6_36_2
  doi: 10.1124/mol.61.6.1377
– ident: e_1_2_6_31_2
  doi: 10.1111/j.1469-7793.1999.0591t.x
– ident: e_1_2_6_26_2
  doi: 10.1002/ana.10473
– ident: e_1_2_6_44_2
  doi: 10.1053/seiz.2001.0594
– ident: e_1_2_6_14_2
  doi: 10.1002/ana.410400306
– ident: e_1_2_6_41_2
  doi: 10.1152/jn.1992.67.6.1698
– ident: e_1_2_6_21_2
  doi: 10.1113/jphysiol.1993.sp019912
– ident: e_1_2_6_32_2
  doi: 10.1016/S0074-7742(08)60304-9
– ident: e_1_2_6_29_2
  doi: 10.1212/WNL.49.3.881
– ident: e_1_2_6_46_2
  doi: 10.1002/ana.410370204
– ident: e_1_2_6_6_2
  doi: 10.1212/01.WNL.0000055433.55136.55
– ident: e_1_2_6_27_2
  doi: 10.1016/j.clinph.2004.12.004
– ident: e_1_2_6_4_2
  doi: 10.1212/01.WNL.0000150932.48688.BE
– ident: e_1_2_6_42_2
  doi: 10.1152/jn.1992.67.1.227
– ident: e_1_2_6_28_2
  doi: 10.1007/BF00228633
– ident: e_1_2_6_23_2
  doi: 10.1111/j.1469-7793.1998.181bi.x
SSID ssj0007673
Score 2.016605
Snippet Purpose: To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).  Methods: PGB, 600...
Purpose: To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).   Methods: PGB, 600...
To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS). PGB, 600 mg/day, was orally...
To explore acute effects of pregabalin (PGB) on human motor cortex excitability with transcranial magnetic stimulation (TMS).PURPOSETo explore acute effects of...
SourceID unpaywall
proquest
pubmed
pascalfrancis
crossref
wiley
SourceType Open Access Repository
Aggregation Database
Index Database
Enrichment Source
Publisher
StartPage 813
SubjectTerms Adult
Amines - pharmacology
Anticonvulsants - pharmacology
Anticonvulsants. Antiepileptics. Antiparkinson agents
Biological and medical sciences
Calcium Channels - drug effects
Calcium Channels - physiology
Cyclohexanecarboxylic Acids - pharmacology
Double-Blind Method
Evoked Potentials, Motor - drug effects
Evoked Potentials, Motor - physiology
Female
GABA
gamma-Aminobutyric Acid - analogs & derivatives
gamma-Aminobutyric Acid - pharmacology
gamma-Aminobutyric Acid - physiology
Headache. Facial pains. Syncopes. Epilepsia. Intracranial hypertension. Brain oedema. Cerebral palsy
Humans
Intracortical inhibition
Investigative techniques, diagnostic techniques (general aspects)
Male
Medical sciences
Motor Cortex - drug effects
Motor Cortex - physiology
Nervous system
Nervous system (semeiology, syndromes)
Neural Inhibition - drug effects
Neural Inhibition - physiology
Neurology
Neuropharmacology
Neurotransmitter Uptake Inhibitors - pharmacology
Nipecotic Acids - pharmacology
Pharmacology. Drug treatments
Placebos
Pregabalin
Radiodiagnosis. Nmr imagery. Nmr spectrometry
Receptors, GABA-B - drug effects
Receptors, GABA-B - physiology
Recruitment, Neurophysiological - drug effects
Recruitment, Neurophysiological - physiology
Silent period
Transcranial magnetic stimulation
Transcranial Magnetic Stimulation - statistics & numerical data
Voltage‐dependent calcium channel
SummonAdditionalLinks – databaseName: Wiley Online Library - Core collection (SURFmarket)
  dbid: DR2
  link: http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lj9MwELbQHngI8X6Ex-IDR1LFSewk3Falq12kQgWstLfIdpzdaENSNYnocuIn8Ef4U_wSZvJoCdrDgrhUVdtp2njG_j7P5xlCXhrfV4oxbWsA1zYgYggp7aS2TJknUl9FKsKzw_N34uDIf3vMj3v9E56F6epDbDbcMDLa-RoDXKpqHOTcBQbERDDkFLjvTxBPwmVadvVhW0kqEH2ymXl2xENnLOq58ItGK9XNpazgpqVdt4uL4OgNcq0plvL8i8zzMdJtl6r92-Rs-JOdQuVs0tRqor_-Uf_x_9yFO-RWj2jpXueCd8kVU9wjV-d9zv4--bFYmROpAO8XdLY2q7qi75eDVgwMu_rJFS0L-qbv1lLTw-I0UxkKAOg0W-kmgw-AfZtyoPMS3qBTlAmvX9M9CiRA5ebnt-8KrpG8ogtMDagSXuiF-LlJaLsoa3iAgKNzeVLg6U36sc4-9w3MKEoqzx-Qo_3Zp-mB3TeJsDWsq77tBuBlnuBcYzUzYLswq2iXKydMgNvqwE0VM0CaPC1C7ciIpwJQEjM6DZzEVcx7SHaKsjCPCU0Sx5VGGEBsBqY2E3Jsm-EFSNKASDsWCQaHiHVfQR0beeTxb0wKRiPG0cD-nqgYhNGI1xZhG8tlV0XkEja7I5_bGuJmHSBFi7wYnDCGOQETPbIwZVPFIoh4ADjXIo8639zaChEK4XOLuBtn_YtfxFtXvLRBPFscwpMn_2j3lFzvNrxQXvqM7NSrxjwHCFir3Ta4fwF7yUxt
  priority: 102
  providerName: Wiley-Blackwell
Title Pregabalin Exerts Oppositional Effects on Different Inhibitory Circuits in Human Motor Cortex: A Double‐blind, Placebo‐controlled Transcranial Magnetic Stimulation Study
URI https://onlinelibrary.wiley.com/doi/abs/10.1111%2Fj.1528-1167.2006.00544.x
https://www.ncbi.nlm.nih.gov/pubmed/16686645
https://www.proquest.com/docview/67957441
https://onlinelibrary.wiley.com/doi/pdfdirect/10.1111/j.1528-1167.2006.00544.x
UnpaywallVersion publishedVersion
Volume 47
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
journalDatabaseRights – providerCode: PRVBFR
  databaseName: Free Medical Journals
  customDbUrl:
  eissn: 1528-1167
  dateEnd: 20241102
  omitProxy: true
  ssIdentifier: ssj0007673
  issn: 0013-9580
  databaseCode: DIK
  dateStart: 19970101
  isFulltext: true
  titleUrlDefault: http://www.freemedicaljournals.com
  providerName: Flying Publisher
– providerCode: PRVALS
  databaseName: IngentaConnect Open Access Journals
  customDbUrl:
  eissn: 1528-1167
  dateEnd: 20140831
  omitProxy: true
  ssIdentifier: ssj0007673
  issn: 0013-9580
  databaseCode: FIJ
  dateStart: 20001201
  isFulltext: true
  titleUrlDefault: http://www.ingentaconnect.com/content/title?j_type=online&j_startat=Aa&j_endat=Af&j_pagesize=200&j_page=1
  providerName: Ingenta
– providerCode: PRVWIB
  databaseName: Wiley Online Library - Core collection (SURFmarket)
  issn: 0013-9580
  databaseCode: DR2
  dateStart: 19970101
  customDbUrl:
  isFulltext: true
  eissn: 1528-1167
  dateEnd: 99991231
  omitProxy: false
  ssIdentifier: ssj0007673
  providerName: Wiley-Blackwell
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV1Lb9NAEB5VqcRDiPfDPMIeOOLUr13H3KKQqkVKiIBI5WR51-ti1bWtxBYpJ34Cf4Q_xS9h1munDeqhIC6RlXhsxzsz-83OtzMAr6TncW7bwhQIrk1ExGhSwkrMKLFdlng84IHaOzydsYOF9-6IHu3ArNsLo-tDbBbclGU0_loZeBkn2s_vXeDjUAejIJv5XV6Bet4AMeUuo4jNe7C7mM1Hn7s2BgFtWqm1Qk0Z0M0Ftmk-l152a-66VUYrfI2J7n9xGUC9CdfrvIzOvkZZto19m8lr_w4U3d_WnJWTQV3xgfj2R0XI__de7sLtFueSkVbMe7Aj8_twbdpm8h_Az_lSHkcco4CcTNZyWa3I-7JjkKGgrqq8IkVO3rY9XCpymH9JeapoAWScLkWd4gko3yQiyLTAH8hYkYfXb8iIYGjAM_nr-w-O94hfk7lKGPACv2jp-ZmMSTNVC_xAMyTT6DhXezrJxyo9bduaEUW0PHsIi_3Jp_GB2baOMAXOtp7p-Kh7LqNUqBpnGAOjrxEO5dYwxohX-E7CbYmhlCvYUFhRQBOG2MmWIvGt2OG2-wh6eZHLJ0Di2HIiySTiOIkOTw6paqbh-ip0w_DaMsDvlCIUbV111d4jCy_EVzgaoRoN1fVT8QhxNMK1AfZGstS1Ra4g09_Su3NBtYSH-NGAl50ihugpVPonymVRr0LmB9RH9GvAY62f57KMDRnzqAHORmH_4oloo45XFggn80M8ePovN3sGN_QamGKcPodetazlC0SFFe9jPPTB6bcG_xvWYFQR
linkProvider Unpaywall
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtNAEF6hIlEQKv_gAu0eOOLIf7u2uVUhVQJ1iaCVerO863Wx6tpRYouUE4_QF-lL8STM-CfBqIeCuERRkokT78zu9-18O0PIG-U4Qpim1CWAax0QMYSUNBI9SkybJ47whY9nh4NDPj52Ppywk7YdEJ6FaepDrDbcMDLq-RoDHDek-1HOLKBAJne7pAJznAEAytsOB9qCCOnzupaUy9t0s2nrPvOMvqzn2m_qrVX3Z9ECblvS9Lu4DpDeI5tVPosuvkVZ1se69WK1_4Bk3d9sNCpng6oUA_n9jwqQ_-k-PCRbLaile40XPiK3VP6Y3AnatP0TcjWdq9NIAOTP6Wip5uWCfpp1cjEwbEooL2iR0_dtw5aSTvKvqUhRA0CH6VxWKXwA7OusAw0KeIMOUSm8fEf3KPAAkamfPy4FXCN-S6eYHRAFvNBq8TMV03pdlvAAMUeD6DTHA5z0S5metz3MKKoqL56S4_3R0XCst30idAlLq6NbLjiazRmTWNAMCC9MLNJiwvBioLfStRJhKuBNtuSeNCKfJRyAkqlk4hqxJUz7GdnIi1y9IDSODStSXAFoUzC7KY9h5wzbRZ4GXNrQiNt5RCjbIurYyyMLfyNTMBohjga2-ETRIIxGuNSIubKcNYVEbmCz03O6tSHu1wFY1Mhu54UhTAuY64lyVVSLkLs-cwHqauR545xrW849zh2mEWvlrX_xi1jtizc2CEfTCTzZ_ke7XbI5PgoOwoPJ4ceX5G6z_4Vq01dko5xX6jUgwlLs1JH-C0fhUI4
linkToPdf http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3JbtRAEG2hRAogxBrALEkfOOKRt27buUWzKANMGAGRcrPc7XawMLY1YyuTnPgEfoSf4kuo8jKDUQ4BcbEs2-Wtq7pfdb2uIuSVchwhTFPqEsC1DogYTEoasR7Gps1jR_jCx7XDs2N-dOK8OWWnbTkgXAvT5IdYT7ihZdT9NRq4KqK4b-XMAhfI5G4XVGCOMwBAue0w30N-3-jDJpeUy9tws2nrPvOMPq3nyjv1xqo7RbiE3xY39S6uAqS3yc0qK8KL8zBN-1i3Hqwm90jafWbDUfkyqEoxkJd_ZID8T__hPrnbglp62GjhA3JDZQ_JzqwN2z8iP-YLdRYKgPwZHa_UolzS90VHFwPBJoXykuYZHbUFW0o6zT4nIkEOAB0mC1klcAHI11EHOsvhBB0iU3h1QA8p-AEiVT-_fRfwjOg1nWN0QORwoOXipyqi9bgsYQM2R2fhWYYLOOnHMvna1jCjyKq82CUnk_Gn4ZHe1onQJQytjm65oGg2Z0xiQjNweKFjkRYThheBeytdKxamAr_JltyTRuizmANQMpWMXSOyhGk_JltZnqmnhEaRYYWKKwBtCno35TGsnGG76KeBL21oxO00IpBtEnWs5ZEGvzlT0BoBtgaW-ETSILRGsNKIuZYsmkQi15DZ6yndRhDn6wAsamS_08IAugWM9YSZyqtlwF2fuQB1NfKkUc6NLOce5w7TiLXW1r94I1br4rUFgvF8CjvP_lFun-zMR5Pg3fT47XNyq5n-QrLpC7JVLir1EgBhKfZqQ_8FgYBQEg
linkToUnpaywall http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwrV3NbtNAEB5VqQRUqPwWXKDsgSMO_tt13FsUUrVICZEgUjlZ3vW6WJi1ldgi5cQj8CJ9KZ6EWf-kDeqhIC6RlXhsxzsz-83OtzMAr6TncW7bwhQIrk1ExGhSwkrMKLFdlng84IHeOzyZsuO59-6Unm7BtNsL09SHWC-4acuo_bU28CJOGj__5gofhzoYBdnM7_IK1PP6iCm3GUVs3oPt-XQ2_NS1MQho3UqtFarLgK4vsEnzufayG3PX3SJa4mtMmv4X1wHUHbhdqSI6_xZl2Sb2rSevo3uQd3-74ax86Vcl74vvf1SE_H_v5T7stjiXDBvFfABbUj2EW5M2k_8ILmYLeRZxjAIUGa_kolyS90XHIEPBpqrykuSKvG17uJTkRH1OeappAWSULkSV4gkoXyciyCTHH8hIk4dXh2RIMDTgmfz14yfHe8SvyUwnDHiOX7T0_EzGpJ6qBX6gGZJJdKb0nk7yoUy_tm3NiCZanj-G-dH44-jYbFtHmAJnW890fNQ9l1EqdI0zjIHR1wiHcmsQY8QrfCfhtsRQyhVsIKwooAlD7GRLkfhW7HDb3YOeypV8CiSOLSeSTCKOk-jw5IDqZhqur0M3DK8tA_xOKULR1lXX7T2y8Ep8haMR6tHQXT81jxBHI1wZYK8li6a2yA1kDjb07lJQL-EhfjTgZaeIIXoKnf6JlMyrZcj8gPqIfg140ujnpSxjA8Y8aoCzVti_eCJaq-ONBcLx7AQP9v_lZs_gTrMGphmnz6FXLir5AlFhyQ9aU_8N48hTKA
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Pregabalin+exerts+oppositional+effects+on+different+inhibitory+circuits+in+human+motor+cortex%3A+a+double-blind%2C+placebo-controlled+transcranial+magnetic+stimulation+study&rft.jtitle=Epilepsia+%28Copenhagen%29&rft.au=Lang%2C+Nicolas&rft.au=Sueske%2C+Elke&rft.au=Hasan%2C+Alkomiet&rft.au=Paulus%2C+Walter&rft.date=2006-05-01&rft.issn=0013-9580&rft.volume=47&rft.issue=5&rft.spage=813&rft_id=info:doi/10.1111%2Fj.1528-1167.2006.00544.x&rft.externalDBID=NO_FULL_TEXT
thumbnail_l http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0013-9580&client=summon
thumbnail_m http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0013-9580&client=summon
thumbnail_s http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0013-9580&client=summon